Skip to search formSkip to main contentSkip to account menu

Repaglinide:PrThr:Pt:Ser/Plas:Ord

Known as: Repaglinide SerPl Ql, Repaglinid:MevcE?ik:Zml?:Ser/Plaz:Srl, Repaglinida:ACnc:Pt:Sor/Plas:Ord 
National Institutes of Health

Related topics

Related topics

3 relations
PlasSerumrepaglinide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney function.
We describe AHA utilization pattern according to age and renal function in type 2 diabetes mellitus (T2DM), in real-life… 
2017
2017
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney function
We describe AHA utilization pattern according to age and renal function in type 2 diabetes mellitus (T2DM), in real-life… 
Review
2014
Review
2014
Antidiabetika bei Patienten mit Niereninsuffizienz
  • D. Czock
  • Der Nephrologe
  • 2014
  • Corpus ID: 19555247
ZusammenfassungHintergrundViele Antidiabetika müssen bei Niereninsuffizienz angepasst werden.FragestellungDosisanpassung von… 
Review
2014
Review
2014
Assessment of Pancreatic β-Cell Function: Review of Methods and Clinical Applications
Type 2 diabetes mellitus (T2DM) is characterized by a progressive failure of pancreatic β-cell function (BCF) with insulin… 
2013
2013
INFLUENCE OF HYDROXYPROPYL-β-CYCLODEXTRIN ON REPAGLINIDE RELEASE FROM SUSTAINED RELEASE BIOADHESIVE BUCCAL TABLETS
Objective: The purpose of this investigation was to study the influence of cyclodextrin complexation on development of sustained… 
2012
2012
Repaglinide
Repaglinide, a carbamoylmethyl benzoic acid derivative, is the first of a new class of oral antidiabetic agents designed to… 
2011
2011
Dimethylaminopyridine repaglinide eutectic
The invention relates to a dimethylaminopyridine repaglinide eutectic formed through combining dimethylaminopyridine with… 
2007
2007
Le répaglinide Antidiabétiques oraux : portrait de famille (4e partie)
Apres la metformine, les sulfamides hypoglycemiants et les inhibiteurs des alpha-glucosidases intestinales, le « portrait de… 
2000
2000
Compared with repaglinide sulphonylurea treatment in type 2 diabetes is associated with a 2.5-fold increase in symptomatic hypoglycaemia with blood glucose levels < 2.5 mmol/l
1998
1998
REPAGLINIDE VERBESSERT DEN BLUTZUCKER UND DIE LEBENSQUALITAT
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)